DoD Uniform Formulary Blanket Purchase Agreement/Additional Discount Program

Agency: Other Defense Agencies
State: Colorado
Type of Government: Federal
FSC Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
NAICS Category:
  • 325412 - Pharmaceutical Preparation Manufacturing
Posted Date: Sep 19, 2017
Due Date: Oct 13, 2017
Solicitation No: HT940217Q0010
Bid Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page
Solicitation Number :
HT940217Q0010
Notice Type :
Combined Synopsis/Solicitation
Synopsis :
Added: Aug 18, 2017 5:57 pm
BACKGROUND: The Department of Defense (DoD) is required by law (10 U.S.C. 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: November 2017. The following drug classes/subclass and agents will be reviewed:



Oncological Sub-Class: Multiple Myeloma
Alkeran, Farydak, Melphalan, Ninlaro, Pomalyst, Revlimid, Thalomid


Weight Loss Agents
Belviq, Belviq XR, Contrave, Qsymia, Saxenda, Xenical


RFQ: The RFQ, including UF BPA and UF ADP Appendices are attached herein. The historical utilization data including quantity dispensed and 30 day equivalents by month is also attached herein.

PRE-PROPOSAL CONFERENCE: See paragraphs 2.4 and 2.5 of the RFQ. Minutes will be posted herein.


CLINICAL PRESENTATIONS: Interested parties or potential offerors may provide clinical presentations. To schedule, call 1-210-536-6116. Clinical presentations must be made available on CD (not to be retained by POD San Antonio staff) at time of presentation. Flash drives are not authorized for use on DoD computers. We are also requesting a dossier. A few weeks prior to the meeting, we will send you a list of detailed questions.

POCs: See below and paragraph 2.3 of the RFQ.

For additional information, search for DoD Pharmacy and Therapeutics (P&T) Committee at http://www.health.mil/.

Please consult the list of document viewers if you cannot open a file.
Appendix Oncological Agents/Multiple Myeloma
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Appendix Oncological Agents/Multiple Myeloma
Posted Date:
August 18, 2017
Appendix_Oncological_Agents_Multiple_Myeloma_(LOCKED... (29.90 Kb)
Download/View Appendix_Oncological_Agents_Multiple_Myeloma_(LOCKED).docx
Description: Appendix Oncological Agents/Multiple Myeloma
Appendix Weight Loss Agents
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Appendix Weight Loss Agents
Posted Date:
August 18, 2017
Description: Appendix Weight Loss
HT940217Q0010
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
HT940217Q0010
Posted Date:
August 18, 2017
Description: HT940217Q0010
Utilization
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Utilization
Posted Date:
August 18, 2017
Description: Utilization Data
Questions and Answers
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Questions and Answers
Posted Date:
September 19, 2017
Description: Q&A
Contracting Office Address :
16401 E. CenterTech Pkwy.
Aurora, Colorado 80011
United States
Primary Point of Contact. :
Yvette H. Dluhos,
Contract Specialist
Phone: 303-676-3994

Related Document

Aug 20, 2017[Combined Synopsis/Solicitation] DoD Uniform Formulary Blanket Purchase Agreement/Additional Discount Program

Sign-up for a Free Trial, Government Bid Alerts

With Free Trial, you can:

You will have a full access to bids, website, and receive daily bid report via email and web.

Try One Week FREE Now

See Also

Marathon TR-10 Baler Reline Details Due Date: 08/31/2020 2:00 pm Bidding Number: RFP

Boulder County

Bid Due: 8/31/2020

Wireless Headset System Active Contract Opportunity Notice ID W50S6V20Q0037 Related Notice Department/Ind. Agency

DEPT OF DEFENSE

Bid Due: 8/17/2020

Hill Rom Call System Maintenance Active Contract Opportunity Notice ID W81K00-20-Q-0208 Related Notice

DEPT OF DEFENSE

Bid Due: 8/14/2020

Unemployment Insurance Systems Robotic Process Automation RFP : 2021000026 Summary CDLE - Division

State Government of Colorado

Bid Due: 8/24/2020